E157 - (CME) Wide Awake: An Update on Best Practices for the Treatment and Management of Insomnia
NEI Podcast
00:00
Cannabinoids and Insomnia
The data for psychiatric indications is not good. For insomnia and certainly for anxiety, it's very mixed. There are pharmacokinetic considerations with marijuana. I would mention Adenosine because of the pain defects. It's the worst. They're being developed. And developing a way in which we can administer CBTR cells or developing a referral network of CBT therapists could be really important to treat insomnia.
Transcript
Play full episode
